Clinical Trials in Metastatic and Recurrent Melanoma

Friday, March 11, 2022

3:12 PM – 3:23 PM CST

Location: HUB Immuno-Oncology Zone

HUB Presenter(s)

Tawnya L. Bowles, MD

Medical Director for Melanoma Services
Intermountain Medical Center
Murray, UT, United States

Disclosure: Amgen (Individual(s) Involved: Self): Research Grant or Support; Asana BioSciences, LLC; Bristol-Myers Squibb; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; and Replimune Group Inc. (Individual(s) Involved: Self): Research Grant or Support; Genentech (Individual(s) Involved: Self): Research Grant or Support

Participants should be aware of the following financial/non-financial relationships:

Tawnya L. Bowles, MD: Amgen (Individual(s) Involved: Self): Research Grant or Support; Asana BioSciences, LLC; Bristol-Myers Squibb; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; and Replimune Group Inc. (Individual(s) Involved: Self): Research Grant or Support; Genentech (Individual(s) Involved: Self): Research Grant or Support